Current and future therapy for pulmonary hypertension in patients with right and left heart failure.
Pulmonary hypertension (PH) is a devastating condition that without proper management can deteriorate progressively. Elevated pulmonary artery pressure without an identifiable etiology is called IPAH. PH resulting from a specific disease is referred to as secondary PH; left-sided cardiac disease can lead to an increase in pulmonary artery pressure resulting in increased vascular resistance and subsequent structural remodeling. If left-sided failure progresses to right-sided failure with high pulmonary artery pressure, the outcome is ominous. It has been clearly proven that early diagnosis and effective medical therapy can markedly decrease morbidity and mortality. In this review, we discuss the current treatment modalities and their limitations for PH secondary to heart failure. Conventional therapy in patients with pulmonary arterial hypertension as well as recent advances in the medical management of PH in general, are also described. Last, the surgical management of these patients and other promising interventional modalities are reviewed.
Division of Cardiothoracic Surgery, University of Illinois at Chicago, 840 S Wood St, CSB 417 (MC 958), Chicago, IL 60612, USA.
Khaled
K
Abdelhady
Patricia
P
Gramling-Babb
Sawsan
S
Awad
Abdallah G
AG
Rebeiz
Payam
P
Salehi
Ahmad
A
Chaudhry
Michael
M
Diodato
Lona Ernst
LE
Rizkallah
Edgar G
EG
Chedrawy
Sunil
S
Prasad
Malek G
MG
Massad
D000818:Animals; D003937:Diagnosis, Differential; D042241:Early Diagnosis; D006333:Heart Failure / Q000150:complications*; D006801:Humans; D006976:Hypertension, Pulmonary / Q000145:classification / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D008168:Lung / Q000098:blood supply